Anti-Asthmatic and COPD Drugs Market - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By Therapy (Preventive, Curative), By Route of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60), By Prescription (Prescription, Over The Counter (OTC)), By Drug Type (Branded, Generic) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 345 | Published : August 2021 | SKU CODE : o&s314 | Format :

Request Sample

Anti-Asthmatic and COPD Drugs Definition

The anti-asthmatics and COPD drugs market consists of sales of anti-asthmatics and COPD drugs by entities (organizations, sole traders and partnerships) that manufacture anti-asthmatics and COPD drugs which are used to prevent and treat asthma and chronic obstructive pulmonary disease (COPD). The anti-asthmatics and COPD drug industry includes establishments that manufacture anti-asthmatics and COPD drugs such as bronchodilators, anti-inflammatory drugs, monoclonal antibodies and combination drugs.

Asthma is a condition that causes the airways in the body to narrow and swell and generate extra mucus. This can make breathing difficult, resulting in coughing, wheezing on exhalation and shortness of breath. Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes airflow obstruction in the lungs. Breathing difficulties, cough, mucus production and wheezing are all symptoms.

Anti-Asthmatic and COPD Drugs Size

The global anti-asthmatics and COPD drugs market reached a value of nearly $75,376.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.7% since 2015. The market is expected to grow from $75,376.4 million in 2020 to $86,436.2 million in 2025 at a rate of 2.8%. The anti-asthmatics and COPD drugs market is then expected to grow at a CAGR of 5.8% from 2025 and reach $114,413.5 million in 2030.  

Growth factors in the historic period include increased prevalence of respiratory diseases, increased incidence of tobacco smoking, global warming, geriatric population, emerging markets, new methods for drug discovery, and rise in healthcare expenditure. The market was restrained by expiration of patents, political uncertainties.

Going forward increased popularity of e-cigarettes/ vaping, rising obesity levels, technology, large pool of undiagnosed population, use of anti-asthmatics and COPD drugs to treat COVID-19 patients, increasing consumption of fats will drive the growth in the anti-asthmatics and COPD drugs market. Factors that could hinder the growth of the market in the future include side effects associated with respiratory drugs, reduction in free trade, stringent regulations.

Anti-Asthmatic and COPD Drugs Drivers

The key drivers of the anti-asthmatic and COPD drugs market include:

Increased Popularity Of E-Cigarettes/ Vaping

E-cigarette, a substitute of direct tobacco smoking is gaining popularity. E-cigarette smoking/ vaping incurs risk of developing asthma among individuals as it contains nicotine extracts from tobacco. E-cigarettes which are also known as e-cigs, vaporizer cigarettes, and vape pens are electronic battery-operated devices that emit doses of vaporized nicotine, or non-nicotine solutions to provide a similar sensation of inhaling tobacco to the user. The usage of e-cigs has been increasing. For instance, in the USA, as of 2020, 19.6% of high school students and 4.7% of middle school students were reported using an e-cigarette. The number of users of e-cigarettes is expected to increase further.  Rising adoption of e-cigs will increase the number of asthma patients in the forecast period, which in turn is expected to drive the anti-asthmatics and COPD drugs market during this period.  

Anti-Asthmatic and COPD Drugs Restraints

The key restraints on the anti-asthmatic and COPD market include:

Side Effects Associated With Respiratory Drugs

Side effects associated with respiratory drugs are expected to limit the growth of the market in the forecast period. Asthma and CPOD patients suffer from several side effects of respiratory drugs. The major side effects include dry mouth, headaches, constipation, fast heartbeat, muscle cramps and shaking.  Inhaled steroids used for asthma treatment can sometime cause thrush (a yeast infection in the mouth) and hoarseness. Therefore, doctors are increasingly recommending alternate therapy such as herbs and dietary supplements, yoga, relaxation and acupuncture to their patients. An increasingly preference of alternative therapies for the treatment of asthma and COPD is expected to limit the growth of the anti-asthmatic and COPD drugs market in the forecast period.

Anti-Asthmatic and COPD Drugs Trends

The key trends influencing in anti-asthmatic and COPD drugs include:

Use Of Probiotics To Treat Asthma

Probiotics are gaining popularity in the market of anti-asthmatics and COPD drugs for the treatment of patients with asthma. Probiotics can enhance the host immune system through the gut ecosystem and could be beneficial for the treatment of allergic diseases such as asthma. For example, in November 2020, Activated Probiotics, an Australia based company manufacturing premium probiotic products, announced that they are expanding their range and developing probiotic products for the treatment of asthma.

Bioelectric Medicine For Asthma Patients

Companies in the anti-asthmatics and COPD drugs market are increasingly developing bioelectric medicines for the treatment of asthma patients. Bioelectronic Medicine focuses on electrical signaling in the nervous system to tackle a wide range of chronic diseases using miniaturized, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses. In July 2020, electroCore, Inc., a US based bioelectronic medicine company, received FDA approval for nerve stimulator for asthma patients which were potentially affected by the novel coronavirus.

Opportunities And Recommendations In The Anti-Asthmatic and COPD Drugs

Opportunities –The top growth potential in the anti-asthmatics and COPD drugs market by drug class will arise in monoclonal antibodies market, which will gain $5,055.64 million of global annual sales by 2025. The top growth potential in the anti-asthmatics and COPD drugs market by end user will arise in the asthma patients market, which will gain $6,249.5 million of global annual sales by 2025. The top growth potential in the anti-asthmatics and COPD drugs market by distribution channel will arise in general pharmacies market, which will gain $4,863.6 million of global annual sales by 2025. The anti-asthmatics and COPD drugs market size will gain the most in the China’s anti-asthmatics and COPD drugs market at $4,273.5 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the anti-asthmatics and COPD drugs companies to focus on invest in probiotic drugs, focus on bioelectric medicines, leverage e-commerce to maximize reach and revenues, leverage online pharmacies, provide competitively priced offerings in low-income countries to reach new users, premium pricing for branded drugs, companies should focus on increasing awareness on asthma and COPD, leveraging medical advice that asthmatics should ensure they consistently stay up to date with preventative medication to protect against COVID 19, target geriatric populations

Anti-Asthmatic and COPD Drugs Segmentation

The anti-asthmatic and COPD drugs market is segmented by drug class, end user, by distribution channel, by therapy, by route of administration, by age group, by prescription, by drug type and by geography.
By Drug Class –
The anti-asthmatic and COPD market is segmented by drug class into
    • a) Bronchodilators
    • b) Monoclonal Antibodies
    • c) Anti-inflammatory Drugs
    • d) Combination Drugs
The combination drugs market was the largest segment of the anti-asthmatics and COPD drugs market segmented by drug class, accounting for 37.4% of the total in 2020. Going forward, the monoclonal antibodies market segment is expected to be the fastest growing segment in the anti-asthmatics and COPD drugs market segmented by drug class, at a CAGR of 6.3% during 2020-2025.
By End User –
The anti-asthmatic and COPD market is segmented by end user into
    • a) Asthma Patients
    • b) COPD Patients
The asthma patients end user market was the largest segment of the anti-asthmatics and COPD drugs market segmented by end user, accounting for 61.6% of the total in 2020. Going forward, the COPD patients end user market segment is expected to be the fastest growing segment in the anti-asthmatics and COPD drugs market segmented by end user, at a CAGR of 3.1% during 2020-2025.
By Distribution Channel –
The anti-asthmatic and COPD market is segmented by distribution channel into
    • a) General Pharmacies
    • b) Hospital Pharmacies
    • c) Online Retailers
The general pharmacies distribution channel market was the largest segment of the anti-asthmatics and COPD drugs market segmented by distribution channel, accounting for 65.3% of the total in 2020. Going forward, the online retailers distribution channel market segment is expected to be the fastest growing segment in the anti-asthmatics and COPD drugs market segmented by distribution channel, at a CAGR of 8.0% during 2020-2025.
By Therapy –
The anti-asthmatic and COPD market is segmented by therapy into
    • a) Preventive
    • b) Curative
The preventive was the largest segment of the anti-asthmatics and COPD drugs market by therapy, accounting for $40,897.4 million or 54.3% of the total market in 2020.
By Route of Administration –
The anti-asthmatic and COPD market is segmented by route of administration into
    • a) Oral
    • b) Inhaled
    • c) Intravenous
    • d) Subcutaneous
The anti-asthmatics and COPD drugs market is also segmented by route of administration into inhaled, intravenous and subcutaneous, and oral. The inhaled route of administration was the largest segment of the anti-asthmatics and COPD drugs market by route of administration, accounting for $55,104.4 million or 73.1% of the total market in 2020.
By Age Group –
The anti-asthmatic and COPD market is segmented by age group
    • a) Below 5
    • b) 5-14
    • c) 15-60
    • d) Above 60
The 15-69 Years age group was the largest segment of the anti-asthmatics and COPD drugs market by age group, accounting for $37,950.2 million or 50.3% of the total market in 2020.
By Prescription –
The anti-asthmatic and COPD market is segmented by prescription into
    • a) Prescription
    • b) Over The Counter (OTC)
The prescription was the largest segment of the anti-asthmatics and COPD drugs market by prescription, accounting for $70,421.1 million or 93.4% of the total market in 2020.
By Drug Type –
The anti-asthmatic and COPD market is segmented by drug type into
    • a) Branded
    • b) Generic
The branded was the largest segment of the anti-asthmatics and COPD drugs market by drug type, accounting for $72,029.6 million or 95.6% of the total market in 2019.
By Geography –
The anti-asthmatic and COPD market is segmented by geography into
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the anti-asthmatics and COPD drugs market, accounting for 47.1% of the total in 2020. It was followed by the Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the anti-asthmatics and COPD drugs market will be Asia-Pacific and Middle East where growth will be at CAGRs of 6.6% and 4.1% respectively during 2020-2025. These will be followed by Africa and North America, where the markets are expected to register CAGRs of 2.9% and 1.8% respectively during 2020-2025.

Anti-Asthmatic and COPD Drugs Competitive Landscape

Major Competitors In The Anti-Asthmatic and COPD Drugs Market Are:

  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Other Competitors In The Anti-Asthmatic and COPD Drugs Market Include:

  • Sanofi S.A.
  • Chiesi Farmaceutici S.p.A.
  • Teva Pharmaceutical Industries Limited
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Ache
  • Adcock Ingram
  • Apotex Inc
  • ASGEN Pharmaceutical Co., Ltd
  • Aspen Nigeria
  • Aurobindo Pharma Limited
  • Bayer
  • Biolab Farmaceuticad
  • Bristol Myers Squibb
  • China Meheco Group Co., Ltd
  • China National Pharmaceutical Group Co., ., Ltd. (Sinopharm)
  • Cipla Limited
  • Cristalia
  • Daewoong Pharmaceutical Co., Ltd
  • EMS Pharma
  • Eurofarma
  • Hanmi Pharmaceutical
  • Hypermarcas
  • Jiangsu Hengrui Medicine Co., Ltd
  • Julphar
  • KYORIN Holdings, Inc
  • Libbs
  • Lupin Limited
  • Mylan
  • Neopharma
  • Nichi-Iko Pharmaceutical Co., Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer
  • Shanghai Acebright Pharmaceuticals Group Co., Ltd.
  • Shanghai Anovent Pharma
  • Vectura Group
    1. Table Of Contents

      Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

      Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2020

      Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2020

      Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

      Table 5: Prevalence Of Asthma, 2015-2019

      Table 6: Prevalence Of COPD, 2015-2019

      Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020

      Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020

      Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020

      Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020

      Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020

      Table 24: Asia Pacific GDP Per Capita, 2015-2020, $

      Table 25: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands

      Table 26: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 27:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 28: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 29: Air Pollution And Air Quality Index, Asia-Pacific Countries

      Table 30: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 31: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 34: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 35: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 36: China GDP Per Capita, 2015-2020, $

      Table 37: China, Population By Age Group, 2015-2023, Thousands

      Table 38:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 39: China Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 40: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 41: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 42: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 43: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 44: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 45: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio

      Table 46: India GDP Per Capita, 2015-2020, $

      Table 47: India, Population By Age Group, 2015-2023, Thousands

      Table 48:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 49: India Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 50: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 51: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 52: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 53: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 54: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 55: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 56: Japan GDP Per Capita, 2015-2020, $

      Table 57: Japan, Population By Age Group, 2015-2023, Thousands

      Table 58:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 59: Japan Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 60: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 61: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 62: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 63: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 64: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 65: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 66: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 67: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 68: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 69: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 70: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 71: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 72: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 73: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 74: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 75: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 76: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 77: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 78: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 79: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 80: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 81: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 82: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 83: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 84: Western Europe GDP Per Capita, 2015-2020, $

      Table 85: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands

      Table 86:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 87:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 88: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 89: Air Pollution And Air Quality Index in 2018, Western Europe Countries

      Table 90: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 91: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 92: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 93: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 94: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 95: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 96: UK GDP Per Capita, 2015-2020, $

      Table 97: UK, Population By Age Group, 2015-2023, Thousands

      Table 98:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 99: UK Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 100: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 101: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 102: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 103: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 104: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 105: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 106: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 107: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 108: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 109: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 110: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 111: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 112: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 113: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 114: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 115: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 116: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 117: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 118: Eastern Europe GDP Per Capita, 2015-2020, $

      Table 119: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands

      Table 120:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 121:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 122: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 123: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 124: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 125: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 126: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 127: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 128: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 129: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 130: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 131: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 132: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 133: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 134: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 135: North America GDP Per Capita, 2015-2020, $

      Table 136: North America, Population By Age Group, By Country, 2015-2023, Thousands

      Table 137:  North America Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 138:  North America Private Healthcare Expenditure, 2013-2017, $ Billion

      Table 139: North America Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 140: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 141: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 142: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 143: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 144: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 145: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 146: USA GDP Per Capita, 2015-2020, $

      Table 147: USA, Population By Age Group, 2015-2023, Thousands

      Table 148:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 149: USA Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 150: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 151: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 152: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 153: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 154: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 155: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 156: South America GDP Per Capita, 2015-2020, $

      Table 157: South America, Population By Age Group, By Country, 2015-2023, Thousands

      Table 158:  South America Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 159:  South America Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 160: South America Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 161: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 162: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 163: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 164: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 165: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 166: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 167: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 168: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 169: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 170: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 171: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 172: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 173: Middle East GDP Per Capita, 2015-2020, $

      Table 174: Middle East, Population By Age Group, By Country, 2015-2023, Thousands

      Table 175:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 176:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 177: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 178: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 179: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 180: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 181: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 182: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 183: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 184: Africa GDP Per Capita, 2015-2020, $

      Table 185: Africa, Population By Age Group, By Country, 2015-2023, Thousands

      Table 186:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion

      Table 187:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion

      Table 188: Africa Total Population Aged 65 And Above, 2015-2023, Thousands

      Table 189: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million

      Table 190: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million

      Table 191: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 192: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 193: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

      Table 194: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million

      Table 195: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

      Table 196: GlaxoSmithKline – Financial Overview, 2016 - 2020, $ Billion

      Table 197: AstraZeneca plc. –  Financial Overview, 2016 - 2020, $ Billion

      Table 198: Boehringer Ingelheim GmbH – Financial Overview, 2016 - 2020, $ Billion

      Table 199: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion

      Table 200: Novartis AG – Financial Overview, 2016 - 2020, $ Billion

      Table 201: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion

      Table 202: Global Respiratory Diseases Drugs Market, 2020, Split By Region

      Table 203: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region

      Table 204: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2020 – 2025, By Country

      Table 205: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Drug Class, 2020 – 2025

      Table 206: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By End Users, 2020 – 2025

      Table 207: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025

      Table 208: Anti-Asthmatics And COPD Drugs - Market Data Sources

    List Of Tables

      Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis
    • Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2020
    • Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2020
    • Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
    • Table 5: Prevalence Of Asthma, 2015-2019
    • Table 6: Prevalence Of COPD, 2015-2019
    • Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
    • Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
    • Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
    • Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
    • Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
    • Table 24: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 25: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 26: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 27:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 28: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 29: Air Pollution And Air Quality Index, Asia-Pacific Countries
    • Table 30: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 31: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 34: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 35: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 36: China GDP Per Capita, 2015-2020, $
    • Table 37: China, Population By Age Group, 2015-2023, Thousands
    • Table 38:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 39: China Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 40: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 41: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 45: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Millio
    • Table 46: India GDP Per Capita, 2015-2020, $
    • Table 47: India, Population By Age Group, 2015-2023, Thousands
    • Table 48:  India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 49: India Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 50: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 51: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 52: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 53: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 54: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: Japan GDP Per Capita, 2015-2020, $
    • Table 57: Japan, Population By Age Group, 2015-2023, Thousands
    • Table 58:  Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 59: Japan Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 60: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 61: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 62: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 65: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 66: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 67: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 68: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 69: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 70: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 71: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 72: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 73: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 77: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 78: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 79: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 80: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 81: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 82: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 83: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 84: Western Europe GDP Per Capita, 2015-2020, $
    • Table 85: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 86:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 87:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 88: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 89: Air Pollution And Air Quality Index in 2018, Western Europe Countries
    • Table 90: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 91: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 92: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 95: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 96: UK GDP Per Capita, 2015-2020, $
    • Table 97: UK, Population By Age Group, 2015-2023, Thousands
    • Table 98:  UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 99: UK Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 100: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 101: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 102: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 103: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 104: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 105: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 106: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 107: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 108: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 109: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 110: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 111: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 112: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 113: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 114: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 115: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 116: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 117: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 118: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 119: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 120:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 121:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 122: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 123: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 124: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 125: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 126: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 127: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 128: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 129: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 130: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 131: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 132: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 133: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 134: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 135: North America GDP Per Capita, 2015-2020, $
    • Table 136: North America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 137:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 138:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
    • Table 139: North America Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 140: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 141: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 142: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 143: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 144: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 145: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 146: USA GDP Per Capita, 2015-2020, $
    • Table 147: USA, Population By Age Group, 2015-2023, Thousands
    • Table 148:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 149: USA Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 150: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 151: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 152: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 153: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 154: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 155: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 156: South America GDP Per Capita, 2015-2020, $
    • Table 157: South America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 158:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 159:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 160: South America Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 161: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 162: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 163: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 164: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 165: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 166: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 167: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 168: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 169: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 170: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 171: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 172: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 173: Middle East GDP Per Capita, 2015-2020, $
    • Table 174: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 175:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 176:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 177: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 178: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 179: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 180: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 181: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 182: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 183: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 184: Africa GDP Per Capita, 2015-2020, $
    • Table 185: Africa, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 186:  Africa Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 187:  Africa Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 188: Africa Total Population Aged 65 And Above, 2015-2023, Thousands
    • Table 189: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Table 190: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 191: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 192: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 193: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 194: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 195: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 196: GlaxoSmithKline – Financial Overview, 2016 - 2020, $ Billion
    • Table 197: AstraZeneca plc. –  Financial Overview, 2016 - 2020, $ Billion
    • Table 198: Boehringer Ingelheim GmbH – Financial Overview, 2016 - 2020, $ Billion
    • Table 199: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
    • Table 200: Novartis AG – Financial Overview, 2016 - 2020, $ Billion
    • Table 201: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Table 202: Global Respiratory Diseases Drugs Market, 2020, Split By Region
    • Table 203: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    • Table 204: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 205: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Drug Class, 2020 – 2025
    • Table 206: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By End Users, 2020 – 2025
    • Table 207: Global Anti-Asthmatics And COPD Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 208: Anti-Asthmatics And COPD Drugs - Market Data Sources

    List Of Figures

      Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class
    • Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User
    • Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel
    • Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy
    • Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration
    • Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group
    • Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription
    • Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type
    • Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs
    • Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020
    • Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020
    • Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients’ Age Group, 2020
    • Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020
    • Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020
    • Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015 – 2020, $ Million
    • Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 99: GlaxoSmithKline – Financial Overview, 2016 – 2020, $ Billion
    • Figure 100: AstraZeneca plc. – Financial Overview 2016 –  2020, $ Billion
    • Figure 101: Boehringer Ingelheim GmbH – Financial Overview, 2016 – 2020, $ Billion
    • Figure 102: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
    • Figure 103: Novartis AG – Financial Overview, 2016 – 2020, $ Billion
    • Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 – 2025, $ Billion
    • Figure 105: Global Respiratory Diseases Drugs Market, 2020, Split By Region
    • Figure 106: Global Respiratory Diseases Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021 - By Drugs Type (Avastin, Tecentriq, Cometriq, Eylea), By Route Of Administration (Oral, Intravenous), By Application (Oncology, Ophthalmology), COVID-19 Growth And Change
    View Report
    Checkpoint Inhibitors Global Market Report 2021 - By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
    View Report
    TNF Alpha Inhibitors Global Market Report 2021 - By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab), By Route Of Administration (Oral, Subcutaneous, Intravenous), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis), COVID-19 Growth And Change
    View Report
    HER2 Inhibitors Global Market Report 2021 - By Treatment (Monotherapy, Combination Therapy), By Application (Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer), By End User (Hospitals, Clinics), COVID-19 Growth And Change
    View Report
    Interleukin Inhibitors Global Market Report 2021 - By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
    View Report
    Immunosuppressants Global Market Report 2021 - By Drug Class (Corticosteroids, Monoclonal Antibodies (MAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
    View Report
    Nucleic Acid Based Gene Therapy Global Market Report 2021 - By Technology (Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), COVID-19 Growth And Change
    View Report
    Protein Inhibitors Global Market Report 2021 - By Product (Protein Kinase Inhibitors, Monoclonal Antibody), By Application (Oncology, Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies), COVID-19 Growth And Change
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)